US Stock MarketDetailed Quotes

IRMD IRadimed

Watchlist
  • 55.850
  • +0.030+0.05%
Trading Nov 8 11:22 ET
707.81MMarket Cap38.25P/E (TTM)

IRadimed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
11.04%18.33M
11.15%17.93M
13.72%17.6M
23.00%65.56M
17.42%17.45M
23.10%16.5M
26.80%16.13M
25.70%15.48M
27.48%53.3M
25.19%14.86M
Operating revenue
11.04%18.33M
11.15%17.93M
13.72%17.6M
23.00%65.56M
17.42%17.45M
23.10%16.5M
26.80%16.13M
25.70%15.48M
27.48%53.3M
25.19%14.86M
Cost of revenue
12.73%4.13M
-0.62%3.92M
12.17%4.21M
28.15%15.4M
10.87%4.04M
28.02%3.67M
52.76%3.94M
28.06%3.75M
23.10%12.02M
38.89%3.64M
Gross profit
10.55%14.19M
14.96%14.01M
14.22%13.39M
21.50%50.16M
19.54%13.41M
21.77%12.84M
20.19%12.19M
24.97%11.72M
28.81%41.28M
21.30%11.22M
Operating expense
21.21%8.4M
16.05%8.38M
11.99%8.64M
17.42%30.12M
18.47%8.25M
8.14%6.93M
20.93%7.22M
22.36%7.71M
15.39%25.65M
13.46%6.97M
Selling and administrative expenses
19.81%7.76M
21.08%7.58M
12.97%7.82M
16.63%27.26M
19.51%7.6M
9.47%6.48M
17.91%6.26M
19.62%6.92M
15.00%23.38M
12.69%6.36M
-Selling and marketing expense
32.50%3.8M
17.91%3.48M
27.57%3.83M
-4.24%12.14M
-9.16%3.33M
-5.69%2.86M
1.40%2.95M
-2.27%3M
20.12%12.68M
17.43%3.67M
-General and administrative expense
9.76%3.97M
23.90%4.1M
1.80%3.99M
41.37%15.12M
58.47%4.27M
25.45%3.62M
37.88%3.31M
44.35%3.92M
9.47%10.7M
6.84%2.7M
Research and development costs
41.30%639.47K
-16.72%801.13K
3.44%821K
25.49%2.86M
7.56%650.44K
-7.95%452.56K
45.18%961.95K
52.90%793.72K
19.58%2.28M
22.21%604.74K
Operating profit
-1.97%5.79M
13.38%5.63M
18.49%4.75M
28.21%20.04M
21.30%5.16M
42.91%5.91M
19.12%4.96M
30.32%4.01M
59.18%15.63M
36.80%4.25M
Net non-operating interest income expense
220.38%1.86M
1,571.70%581.85K
Non-operating interest income
----
----
----
220.38%1.86M
----
----
----
----
1,571.70%581.85K
----
Other net income (expense)
25.04%629.2K
91.49%642.22K
44.61%495.15K
-461.13%-161.32K
-915.98%-1.34M
378.40%503.19K
2,459.82%335.39K
2,395.74%342.41K
-77.45%-28.75K
-327.90%-132.12K
Gain on sale of security
----
----
----
-417.75%-148.84K
----
----
----
----
-77.45%-28.75K
----
Special income (charges)
----
----
----
---12.47K
----
----
----
----
--0
----
-Gain on sale of property,plant,equipment
----
----
----
---12.47K
----
----
----
----
--0
----
Other non- operating income (expenses)
25.04%629.2K
91.49%642.22K
44.61%495.15K
----
----
378.40%503.19K
2,459.82%335.39K
2,395.74%342.41K
----
----
Income before tax
0.15%6.42M
18.32%6.27M
20.55%5.24M
34.35%21.74M
20.79%5.68M
51.23%6.41M
26.77%5.3M
42.15%4.35M
64.50%16.18M
51.07%4.7M
Income tax
2.05%1.37M
22.30%1.37M
17.31%1.11M
35.59%4.55M
10.87%1.14M
65.52%1.34M
19.17%1.12M
64.59%943.59K
556.26%3.35M
232.19%1.03M
Net income
-0.35%5.05M
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
37.56%12.83M
-5.63%3.67M
Net income continuous Operations
-0.35%5.05M
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
37.56%12.83M
-5.63%3.67M
Minority interest income
Net income attributable to the parent company
-0.35%5.05M
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
37.56%12.83M
-5.63%3.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-0.35%5.05M
17.26%4.9M
21.45%4.14M
34.02%17.19M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
37.56%12.83M
-5.63%3.67M
Basic earnings per share
0.00%0.4
18.18%0.39
22.22%0.33
33.33%1.36
24.14%0.36
48.15%0.4
26.92%0.33
35.00%0.27
34.21%1.02
-6.45%0.29
Diluted earnings per share
0.00%0.4
15.15%0.38
18.52%0.32
32.35%1.35
24.14%0.36
48.15%0.4
26.92%0.33
35.00%0.27
37.84%1.02
-6.45%0.29
Dividend per share
0.15
0.15
0
0.15
0.15
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 11.04%18.33M11.15%17.93M13.72%17.6M23.00%65.56M17.42%17.45M23.10%16.5M26.80%16.13M25.70%15.48M27.48%53.3M25.19%14.86M
Operating revenue 11.04%18.33M11.15%17.93M13.72%17.6M23.00%65.56M17.42%17.45M23.10%16.5M26.80%16.13M25.70%15.48M27.48%53.3M25.19%14.86M
Cost of revenue 12.73%4.13M-0.62%3.92M12.17%4.21M28.15%15.4M10.87%4.04M28.02%3.67M52.76%3.94M28.06%3.75M23.10%12.02M38.89%3.64M
Gross profit 10.55%14.19M14.96%14.01M14.22%13.39M21.50%50.16M19.54%13.41M21.77%12.84M20.19%12.19M24.97%11.72M28.81%41.28M21.30%11.22M
Operating expense 21.21%8.4M16.05%8.38M11.99%8.64M17.42%30.12M18.47%8.25M8.14%6.93M20.93%7.22M22.36%7.71M15.39%25.65M13.46%6.97M
Selling and administrative expenses 19.81%7.76M21.08%7.58M12.97%7.82M16.63%27.26M19.51%7.6M9.47%6.48M17.91%6.26M19.62%6.92M15.00%23.38M12.69%6.36M
-Selling and marketing expense 32.50%3.8M17.91%3.48M27.57%3.83M-4.24%12.14M-9.16%3.33M-5.69%2.86M1.40%2.95M-2.27%3M20.12%12.68M17.43%3.67M
-General and administrative expense 9.76%3.97M23.90%4.1M1.80%3.99M41.37%15.12M58.47%4.27M25.45%3.62M37.88%3.31M44.35%3.92M9.47%10.7M6.84%2.7M
Research and development costs 41.30%639.47K-16.72%801.13K3.44%821K25.49%2.86M7.56%650.44K-7.95%452.56K45.18%961.95K52.90%793.72K19.58%2.28M22.21%604.74K
Operating profit -1.97%5.79M13.38%5.63M18.49%4.75M28.21%20.04M21.30%5.16M42.91%5.91M19.12%4.96M30.32%4.01M59.18%15.63M36.80%4.25M
Net non-operating interest income expense 220.38%1.86M1,571.70%581.85K
Non-operating interest income ------------220.38%1.86M----------------1,571.70%581.85K----
Other net income (expense) 25.04%629.2K91.49%642.22K44.61%495.15K-461.13%-161.32K-915.98%-1.34M378.40%503.19K2,459.82%335.39K2,395.74%342.41K-77.45%-28.75K-327.90%-132.12K
Gain on sale of security -------------417.75%-148.84K-----------------77.45%-28.75K----
Special income (charges) ---------------12.47K------------------0----
-Gain on sale of property,plant,equipment ---------------12.47K------------------0----
Other non- operating income (expenses) 25.04%629.2K91.49%642.22K44.61%495.15K--------378.40%503.19K2,459.82%335.39K2,395.74%342.41K--------
Income before tax 0.15%6.42M18.32%6.27M20.55%5.24M34.35%21.74M20.79%5.68M51.23%6.41M26.77%5.3M42.15%4.35M64.50%16.18M51.07%4.7M
Income tax 2.05%1.37M22.30%1.37M17.31%1.11M35.59%4.55M10.87%1.14M65.52%1.34M19.17%1.12M64.59%943.59K556.26%3.35M232.19%1.03M
Net income -0.35%5.05M17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M37.56%12.83M-5.63%3.67M
Net income continuous Operations -0.35%5.05M17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M37.56%12.83M-5.63%3.67M
Minority interest income
Net income attributable to the parent company -0.35%5.05M17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M37.56%12.83M-5.63%3.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -0.35%5.05M17.26%4.9M21.45%4.14M34.02%17.19M23.58%4.54M47.86%5.07M28.97%4.18M36.97%3.41M37.56%12.83M-5.63%3.67M
Basic earnings per share 0.00%0.418.18%0.3922.22%0.3333.33%1.3624.14%0.3648.15%0.426.92%0.3335.00%0.2734.21%1.02-6.45%0.29
Diluted earnings per share 0.00%0.415.15%0.3818.52%0.3232.35%1.3524.14%0.3648.15%0.426.92%0.3335.00%0.2737.84%1.02-6.45%0.29
Dividend per share 0.150.1500.150.15
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data